NR3C1 and depressive symptom measurement: The use of two approaches to avoid glucocorticoid action, the removal of adrenal glands, or treatment with GR antagonist RU486 (mifepristone), increased hippocampal neurogenesis [108,109,110], strongly suggesting that hypercortisolism is important to the development and/or aggravation of depression.